Ever Supreme Bio Technology is a clinical-stage biotech company focused on developing next-generation allogeneic cell therapies for solid tumors. Its lead candidate, CAR001, combines gamma delta T cells targeting HLA-G with BiTE-mediated PD-L1 engagement to overcome two major barriers in current solid tumor treatment: tumor heterogeneity and immune evasion. With operations in Taiwan and early clinical trials underway, Ever Supreme also runs a revenue-generating CDMO platform and is expanding its pipeline to include stem cell and exosome-based therapies. Backed by a strong IP portfolio across seven countries and deep clinical expertise, the company is strategically positioned to deliver scalable, off-the-shelf immunotherapies that are safe, effective, and globally accessible.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 台中市北屯區經貿路一段360號7樓c2棟, Taichung,406040,taiwan, Province Of China
- Industry
- Biotechnology
- Website
- https://www.ever-supreme.com.tw/
- Keywords
- Hyele Limited.
- HQ
- Taichung
Ever Supreme Bio Technology Co., Ltd. (6712.two) Questions
Ever Supreme Bio Technology Co., Ltd. (6712.Two)'s website is https://www.ever-supreme.com.tw/
Ever Supreme Bio Technology Co., Ltd. (6712.Two)'s LinkedIn profile is https://tw.linkedin.com/company/ever-supreme-bio-technology
Ever Supreme Bio Technology Co., Ltd. (6712.Two) has
10 employees.
View email and phone details for 10
employees at Ever Supreme Bio Technology Co., Ltd. (6712.Two).
Ever Supreme Bio Technology Co., Ltd. (6712.Two)'s industry is
Biotechnology
Ever Supreme Bio Technology Co., Ltd. (6712.Two)'s top competitors are
Eirgenix, Inc.,
Allystar,
Lotus Pharmaceutical Co., Ltd,
Alcarbo Technologies Limited,
Vidi Labs,
Hyele Limited,
Sinew Pharma Inc.,
Quantum International Corp (Qic),
Golden Age Foundation,
Taimed Biologics.
Ever Supreme Bio Technology Co., Ltd. (6712.Two)'s categories are Biotechnology
Ever Supreme Bio Technology Co., Ltd. (6712.Two)'s founding year is 2016
